Neuropilin-1 Facilitates SARS-Cov-2 Cell Entry and Provides a Possible Pathway Into the Central Nervous System
bioRxiv preprint doi: https://doi.org/10.1101/2020.06.07.137802; this version posted June 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system Ludovico Cantuti-Castelvetri1,2*, Ravi Ojha3*, Liliana D. Pedro 1,2*, Minou Djannatian1,2*, Jonas Franz4*, Suvi Kuivanen5*, Katri Kallio3, Tuğberk Kaya1,2,6, Maria Anastasina3,7, Teemu Smura5, Lev Levanov5, Leonora Szirovicza5, Allan Tobi8, Hannimari Kallio-Kokko9, Pamela Österlund10, Merja Joensuu11, Frédéric A. Meunier11, Sarah Butcher3,7, Martin Sebastian Winkler12, Brit Mollenhauer13, Ari Helenius14, Ozgun Gokce6,19, Tambet Teesalu3,15,16, Jussi Hepojoki5,17, Olli Vapalahti5,9,18, Christine Stadelmann4, Giuseppe Balistreri3§, Mikael Simons1,2,19§ 1Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany 2German Center for Neurodegenerative Diseases (DZNE), Munich, Germany 3Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences Research Program, University of Helsinki, Helsinki, Finland 4 Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany 5University of Helsinki, Medicum, Department of Virology, Helsinki, Finland 6 Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany 7Helsinki Institute of Life Sciences-Institute of Biotechnology, University of Helsinki, Finland 8Laboratory of Cancer Biology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia 9University of Helsinki and Helsinki University Hospital, Department of Virology, Helsinki, Finland 10Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland 11Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
[Show full text]